BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

311 related articles for article (PubMed ID: 26293416)

  • 1. Multimodal cancer imaging using lanthanide-based upconversion nanoparticles.
    Yang D; Li C; Lin J
    Nanomedicine (Lond); 2015; 10(16):2573-91. PubMed ID: 26293416
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multifunctional nanomesoporous materials with upconversion (in vivo) and downconversion (in vitro) luminescence imaging based on mesoporous capping UCNPs and linking lanthanide complexes.
    Sun L; Ge X; Liu J; Qiu Y; Wei Z; Tian B; Shi L
    Nanoscale; 2014 Nov; 6(21):13242-52. PubMed ID: 25263544
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intensely red-emitting luminescent upconversion nanoparticles for deep-tissue multimodal bioimaging.
    Deng H; Huang S; Xu C
    Talanta; 2018 Jul; 184():461-467. PubMed ID: 29674069
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lanthanide-doped LiLuF(4) upconversion nanoprobes for the detection of disease biomarkers.
    Huang P; Zheng W; Zhou S; Tu D; Chen Z; Zhu H; Li R; Ma E; Huang M; Chen X
    Angew Chem Int Ed Engl; 2014 Jan; 53(5):1252-7. PubMed ID: 24436151
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multicomponent nanocrystals with anti-Stokes luminescence as contrast agents for modern imaging techniques.
    Generalova AN; Chichkov BN; Khaydukov EV
    Adv Colloid Interface Sci; 2017 Jul; 245():1-19. PubMed ID: 28499601
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Folic acid-conjugated LaF3:Yb,Tm@SiO2 nanoprobes for targeting dual-modality imaging of upconversion luminescence and X-ray computed tomography.
    Ma J; Huang P; He M; Pan L; Zhou Z; Feng L; Gao G; Cui D
    J Phys Chem B; 2012 Dec; 116(48):14062-70. PubMed ID: 23134318
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recent advances of lanthanide-doped upconversion nanoparticles for biological applications.
    Li H; Wang X; Huang D; Chen G
    Nanotechnology; 2020 Feb; 31(7):072001. PubMed ID: 31627201
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Perspectives and challenges of photon-upconversion nanoparticles - Part I: routes to brighter particles and quantitative spectroscopic studies.
    Resch-Genger U; Gorris HH
    Anal Bioanal Chem; 2017 Oct; 409(25):5855-5874. PubMed ID: 28710516
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Water-stable NaLuF4-based upconversion nanophosphors with long-term validity for multimodal lymphatic imaging.
    Zhou J; Zhu X; Chen M; Sun Y; Li F
    Biomaterials; 2012 Sep; 33(26):6201-10. PubMed ID: 22717364
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multifunctional Nano-Bioprobes Based on Rattle-Structured Upconverting Luminescent Nanoparticles.
    Lu S; Tu D; Hu P; Xu J; Li R; Wang M; Chen Z; Huang M; Chen X
    Angew Chem Int Ed Engl; 2015 Jun; 54(27):7915-9. PubMed ID: 26013002
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Upconverting rare-earth nanoparticles with a paramagnetic lanthanide complex shell for upconversion fluorescent and magnetic resonance dual-modality imaging.
    Wang Y; Ji L; Zhang B; Yin P; Qiu Y; Song D; Zhou J; Li Q
    Nanotechnology; 2013 May; 24(17):175101. PubMed ID: 23558298
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synergistic dual-modality in vivo upconversion luminescence/X-ray imaging and tracking of amine-functionalized NaYbF(4):Er nanoprobes.
    Yi Z; Zeng S; Lu W; Wang H; Rao L; Liu H; Hao J
    ACS Appl Mater Interfaces; 2014 Mar; 6(6):3839-46. PubMed ID: 24597514
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recent advances in synthesis and surface modification of lanthanide-doped upconversion nanoparticles for biomedical applications.
    Lin M; Zhao Y; Wang S; Liu M; Duan Z; Chen Y; Li F; Xu F; Lu T
    Biotechnol Adv; 2012; 30(6):1551-61. PubMed ID: 22561011
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficient gene delivery and multimodal imaging by lanthanide-based upconversion nanoparticles.
    Wang L; Liu J; Dai Y; Yang Q; Zhang Y; Yang P; Cheng Z; Lian H; Li C; Hou Z; Ma P; Lin J
    Langmuir; 2014 Nov; 30(43):13042-51. PubMed ID: 25291048
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Core-shell lanthanide upconversion nanophosphors as four-modal probes for tumor angiogenesis imaging.
    Sun Y; Zhu X; Peng J; Li F
    ACS Nano; 2013 Dec; 7(12):11290-300. PubMed ID: 24205939
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Perspectives and challenges of photon-upconversion nanoparticles - Part II: bioanalytical applications.
    Gorris HH; Resch-Genger U
    Anal Bioanal Chem; 2017 Oct; 409(25):5875-5890. PubMed ID: 28687881
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An 800 nm driven NaErF
    Li Q; Li X; Zhang L; Zuo J; Zhang Y; Liu X; Tu L; Xue B; Chang Y; Kong X
    Nanoscale; 2018 Jul; 10(26):12356-12363. PubMed ID: 29694473
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lanthanide-doped upconversion nano-bioprobes: electronic structures, optical properties, and biodetection.
    Zheng W; Huang P; Tu D; Ma E; Zhu H; Chen X
    Chem Soc Rev; 2015 Mar; 44(6):1379-415. PubMed ID: 25093303
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radioisotope post-labeling upconversion nanophosphors for in vivo quantitative tracking.
    Sun Y; Liu Q; Peng J; Feng W; Zhang Y; Yang P; Li F
    Biomaterials; 2013 Mar; 34(9):2289-95. PubMed ID: 23274071
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The biosafety of lanthanide upconversion nanomaterials.
    Sun Y; Feng W; Yang P; Huang C; Li F
    Chem Soc Rev; 2015 Mar; 44(6):1509-25. PubMed ID: 25113504
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.